Datadog, Inc. (NASDAQ: DDOG) Q3 2020 earnings call dated Nov. 10, 2020
Corporate Participants:
AJ Ljubich — Director of Investor Relations
Olivier Pomel — Chief Executive Officer and Co-Founder
David Obstler — Chief Financial Officer
Analysts:
Sanjit Singh — Morgan Stanley — Analyst
Sterling Auty — JPMorgan — Analyst
Chris Merwin — Goldman Sachs — Analyst
Brad Zelnick — Credit Suisse — Analyst
Raimo Lenschow — Barclays — Analyst
Matt Hedberg — RBC Capital Markets — Analyst
Brent Thill — Jefferies — Analyst
Robert Majek — Raymond James — Analyst
Brad Reback — Stifel — Analyst
Jack Andrews — Needham — Analyst
Ittai Kidron — Oppenheimer — Analyst
Bhavan Suri — William Blair — Analyst
Andrew Nowinski — D.A. Davidson — Analyst
_____
To read the full earnings call transcript, click here.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments